Animal Testing and Non-Animal Alternative Testing Global Market Opportunities and Strategies to 2035

This report describes and explains the animal testing and non-animal alternative testing market and covers 2020-2025, termed the historic period, and 2025-2030, 2035F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global animal testing and non-animal alternative testing market reached a value of nearly $15.19 billion in 2025, having grown at a compound annual growth rate (CAGR) of 4.1% since 2020. The market is expected to grow from $15.19 billion in 2025 to $18.9 billion in 2030 at a rate of 4.5%. The market is then expected to grow at a CAGR of 4% from 2030 and reach $23.01 billion in 2035.

Growth in the historic period resulted from increasing pharmaceutical R&D spending, rising prevalence of chronic diseases, growing regulatory requirements for safety testing and rising global burden of infectious diseases. Factors that negatively affected growth in the historic period were high initial investment and ethical concerns and animal welfare activism.

Going forward, expanding biopharmaceutical industry, rising number of drug discovery programs, growing demand for chemical and cosmetic safety testing and growing focus on drug safety validation will drive the growth. Factors that could hinder the growth of the animal testing and non-animal alternative testing market in the future include limited availability of standardized animal models for certain diseases, strict laboratory inspection and compliance requirements and impact of trade wars and tariffs.

Market trends for the animal testing and non-animal alternative testing market include biotechnology, genomics and precision medicine, artificial intelligence and autonomous intelligence, digitalization, cloud, big data and cybersecurity, internet of things (IoT), smart infrastructure and connected ecosystems and sustainability, climate tech and circular economy.

The animal testing and non-animal alternative testing market is segmented by type into animal testing and non-animal alternative testing. The animal testing market was the largest segment of the animal testing and non-animal alternative testing market segmented by type, accounting for 80.1% or $12.17 billion of the total in 2025. Going forward, the non-animal alternative testing segment is expected to be the fastest-growing segment in the animal testing and non-animal alternative testing market segmented by type, at a CAGR of 6.3% during 2025-2030.

The animal testing market is sub-segmented by animal type into mice, rats, frogs, fish, birds, guinea pigs, hamsters, rabbits, sheep, dogs, cats, monkeys, pigs and other animal types. The other animal types market was the largest segment of the animal testing market, sub-segmented by animal type, accounting for 14.7% or $1.78 billion of the total in 2025. Going forward, the rats segment is expected to be the fastest-growing segment in the animal testing market, sub-segmented by animal type, at a CAGR of 5.7% during 2025-2030.

The animal testing and non-animal alternative testing market is segmented by end user application into cosmetics industry, pharmaceutical industry, medical device industry and other end-user applications. The pharmaceutical industry was the largest segment of the animal testing and non-animal alternative testing market segmented by end-user application, accounting for 50.1% or $7.6 billion of the total in 2025. Going forward, the other end-user applications segment is expected to be the fastest-growing segment in the animal testing and non-animal alternative testing market segmented by end-user application, at a CAGR of 5.4% during 2025-2030.

The animal testing and non-animal alternative testing market is segmented by end use industrial application into basic research, applied research, regulatory testing, development of new diagnostic methods, breeding of genetically altered animals and animal cloning. The regulatory testing market was the largest segment of the animal testing and non-animal alternative testing market segmented by end use industrial application, accounting for 26.6% or $4.04 billion of the total in 2025. Going forward, the breeding of genetically altered animals segment is expected to be the fastest-growing segment in the animal testing and non-animal alternative testing market segmented by end use industrial application, at a CAGR of 6% during 2025-2030.

North America was the largest region in the animal testing and non-animal alternative testing market, accounting for 38.6% or $5.87 billion of the total in 2025. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the animal testing and non-animal alternative testing market will be Asia Pacific and Middle East where growth will be at CAGRs of 5.1% and 4.8% respectively. These will be followed by Africa and Eastern Europe where the markets are expected to grow at CAGRs of 4.7% and 4.5% respectively.

The global animal testing and non-animal alternative testing market is highly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 1.67% of the total market in 2024. Bio-Rad Laboratories Inc was the largest competitor with a 0.53% share of the market, followed by SGS SA with 0.29%, BioIVT with 0.25%, Evotec SE with 0.18%, CN Bio Innovations Ltd with 0.084%, Emulate Inc with 0.08%, Japan Tissue Engineering Co. Ltd with 0.078%, InSphero with 0.071%, Charles River Laboratories with 0.067% and TissUse GmbH with 0.04%.

The top opportunities in the animal testing and non-animal alternative testing market segmented by type will arise in the animal testing segment, which will gain $2.62 billion of global annual sales by 2030. The top opportunities in the animal testing market sub-segmented by animal type will arise in the rats segment, which will gain $414.6 million of global annual sales by 2030. The top opportunities in the animal testing and non-animal alternative testing market segmented by end-user application will arise in the pharmaceutical industry segment, which will gain $1.79 billion of global annual sales by 2030. The top opportunities in the animal testing and non-animal alternative testing market segmented by end use industrial application will arise in the regulatory testing segment, which will gain $1.04 billion of global annual sales by 2030. The animal testing and non-animal alternative testing market size will gain the most in the USA at $1.26 billion.

Player-adopted strategies in the animal testing and non-animal alternative testing market include focus on strengthening operational capabilities through strategic partnerships and focus on strengthening operational capabilities through new launches.

Market-trend-based strategies for the animal testing and non-animal alternative testing market include focus on innovations in in vitro modeling enhance drug development while reducing animal use, focus on AI-powered biosimulation supports regulatory-ready non-animal research approaches, focus on next-generation in vitro platforms enhance precision in toxicity and genetic damage detection and focus on technology-driven advancements strengthen the future of ethical research and safety testing.

To take advantage of the opportunities, the analyst recommends the animal testing and non-animal alternative testing companies to focus on advanced organ-on-chip and organoid platforms for scalable preclinical research, focus on AI-enabled biosimulation and computational modeling for non-animal drug development, focus on advanced in vitro toxicity and genotoxicity testing platforms, focus on collaborative non-animal testing innovation and regulatory adoption, focus on non-animal alternative testing solutions, focus on expanding regional distribution networks and digital access, focus on value-based and tiered pricing models, build evidence-led communication strategies, expand stakeholder engagement through multi-channel promotion, focus on breeding of genetically altered animals, focus on cosmetics industry applications.

This product will be delivered within 3-5 business days.